The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStaffline Regulatory News (STAF)

Share Price Information for Staffline (STAF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.20
Bid: 31.60
Ask: 32.80
Change: 0.60 (1.90%)
Spread: 1.20 (3.797%)
Open: 31.60
High: 0.00
Low: 0.00
Prev. Close: 31.60
STAF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Share Buy-back

4 Oct 2023 07:00

RNS Number : 5846O
Staffline Group PLC
04 October 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

4 October 2023

 

Staffline Group plc

("Staffline" or the "Company")

 

Launch of Share Buy-back

Staffline Group plc, the recruitment and training group, today announces its intention to make a series of share repurchases of up to an aggregate of 3,904,598 ordinary shares in the Company (the "Share Buy-back"), being the balance of the unutilised shareholder authority following the previous share buyback launched in August 2023.

 

The Group remains disciplined in its allocation of capital with the main objective being to enhance shareholder value. We continuously assess our medium-term plans which take account of growth prospects, investment in the Republic of Ireland network, cash generation, net borrowings, and leverage. Therefore, the amount allocated to buybacks is based on our predicted trading cash flows and financing headroom.

 

Accordingly, the Company today announces the launch of the Share Buy-back, to repurchase up to 3,904,598 ordinary shares in the capital of the Company (the "Ordinary Shares"). The Ordinary Shares purchased pursuant to the Share Buy-back will be cancelled.

 

The Share Buy-back will be operated in accordance with the terms of the Company's general authority to repurchase Ordinary Shares granted by shareholders at its annual general meeting (the "AGM"), held on 12 June 2023.

 

In accordance with the authority granted at the AGM, a) the aggregate number of Ordinary Shares to be repurchased will not exceed 3,904,598, b) the minimum price which may be paid for each Ordinary Share will be £0.10, and c) the maximum price (excluding expenses) which may be paid for each Ordinary Share will be the higher of: (i) an amount equal to 105 per cent of the average of the middle market quotations for the Ordinary Shares as derived from the AIM Appendix of the Daily Official List of London Stock Exchange plc for the five business days immediately preceding the day on which the purchase is made; and (ii) an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share on the trading venue where the purchase is carried out.

 

Shareholders should be aware that a purchase of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares and could exceed 25 per cent. of the average daily trading volume of the preceding 20 business days. Should that be the case, the Company could exceed the pricing and/or volume restrictions as established by the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) (the "Regulation") and therefore the Share Buy-back may not fall within the safe harbour provisions of the Regulation.

 

As part of the Share Buy-back, Liberum has been appointed to purchase the Ordinary Shares as principal.

 

For further information, please contact:

 

Staffline Group plc

www.stafflinegroupplc.co.uk

Albert Ellis, Chief Executive Officer

Daniel Quint, Chief Financial Officer

via Vigo Consulting

Liberum (Nominated Adviser and Broker)

www.liberum.com

Richard Lindley / Satbir Kler

020 3100 2222

Zeus (Joint Broker)

www.zeuscapital.co.uk

David Foreman (Investment Banking)

Nick Searle (Sales)

020 3829 5000

 

Vigo Consulting (Financial PR)

www.vigoconsulting.com

Jeremy Garcia / Kate Kilgallen

020 7390 0230

Staffline@vigoconsulting.com

 

 

Market Abuse Regulation:

 

For the purposes of MAR, Article 2 of Commission Implementing Regulation (EU) 2016/1055 and the UK version of such implementing regulation, the person responsible for arranging for the release of this Announcement on behalf of the Company is Daniel Quint, Chief Financial Officer.

 

About Staffline

 

About Staffline - Recruitment, Training and Support

Enabling the Future of Workâ„¢

Staffline is the UK's market leading Recruitment and Training group. It has three divisions:

 

Recruitment GB

Staffline is a leading provider of flexible blue-collar workers, supplying c.31,000 staff per day on average from around 400 sites, across a wide range of industries including supermarkets, drinks, driving, food processing, logistics and manufacturing.

 

Recruitment Ireland

The Recruitment Ireland business is a leading end to end solutions provider operating across twenty industries, ten branch locations and ten onsite customer locations, supplying c.4,500 staff per day on average, and offering RPO, MSP, temporary and permanent solutions across the island of Ireland.

 

PeoplePlus Division

Staffline is the leading adult skills and training provider in the UK, delivering adult education, prison education and skills-based employability programmes across the country.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSRILLVIIV
Date   Source Headline
13th Apr 20234:41 pmRNSHolding(s) in Company
12th Apr 202311:56 amRNSHolding(s) in Company
11th Apr 202312:13 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSHolding(s) in Company
30th Mar 202310:31 amRNSDirector/PDMR Shareholding & Total Voting Rights
29th Mar 20236:07 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirectorate Change
27th Mar 20232:34 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNS2022 Audited Results
8th Mar 20237:00 amRNSAnalyst & Investor Presentation
1st Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20234:43 pmRNSDirector/PDMR Shareholding
20th Feb 202312:48 pmRNSEBT Share Purchase
17th Feb 20237:01 amRNSDirector/PDMR Shareholding
17th Feb 20237:00 amRNSGrant of Options under 2023 LTIP
13th Feb 202310:50 amRNSReplacement: Director/PDMR Shareholding
10th Feb 202312:25 pmRNSDirector/PDMR Shareholding
10th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20237:20 amRNSDirector/PDMR Shareholding
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20232:01 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
26th Jan 20233:45 pmRNSEBT Share Purchase
26th Jan 202311:59 amRNSDirector/PDMR Shareholding
25th Jan 202311:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSTrading Update & Notice of Results
19th Jan 20237:00 amRNSAppointment of Joint Broker
13th Jan 20237:00 amRNSNotice of Trading Update & Investor Presentation
23rd Dec 20229:44 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSBoard Update
11th Nov 202210:18 amRNSDirector/PDMR Shareholding
9th Nov 20224:26 pmRNSGrant of Options under SAYE Scheme
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
18th Oct 20225:04 pmRNSDirector/PDMR Shareholding
10th Oct 202210:20 amRNSEBT Share Purchase
3rd Oct 20224:53 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:03 amRNSDirector Declaration
27th Sep 20222:06 pmRNSDirector/PDMR Shareholding
18th Aug 20222:26 pmRNSDirector/PDMR Shareholding
15th Aug 202210:04 amRNSDirector/PDMR Shareholding
11th Aug 20227:01 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 202211:21 amRNSTotal Voting Rights
9th Aug 202211:20 amRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.